Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease

被引：0

作者：

Pieter Jelle Visser

Lianne M. Reus

Johan Gobom

Iris Jansen

Ellen Dicks

Sven J. van der Lee

Magda Tsolaki

Frans R. J. Verhey

Julius Popp

Pablo Martinez-Lage

Rik Vandenberghe

Alberto Lleó

José Luís Molinuevo

Sebastiaan Engelborghs

Yvonne Freund-Levi

Lutz Froelich

Kristel Sleegers

Valerija Dobricic

Simon Lovestone

Johannes Streffer

Stephanie J. B. Vos

Isabelle Bos

August B. Smit

Kaj Blennow

Philip Scheltens

Charlotte E. Teunissen

Lars Bertram

Henrik Zetterberg

Betty M. Tijms

机构：

[1] Vrije Universiteit Amsterdam,Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience

[2] Maastricht University,Alzheimer Center Limburg, School for Mental Health and Neuroscience

[3] Karolinska Institutet,Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics

[4] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory

[5] Sahlgrenska Academy at the University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology

[6] VU University,Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience

[7] Vrije Universiteit Amsterdam,Section Genomics of Neurodegenerative Diseases and Aging, Department of Clinical Genetics

[8] Amsterdam UMC,1St Department of Neurology

[9] AHEPA University Hospital,Old Age Psychiatry

[10] University Hospital Lausanne,Department of Geriatric Psychiatry

[11] University Hospital of Psychiatry and University of Zürich,Laboratory for Cognitive Neurology, Department of Neurosciences

[12] Fundación CITA-Alzhéimer Fundazioa,IIB

[13] Neurology Service,Sant Pau, Hospital de La Santa Creu I Sant Pau

[14] University Hospitals Leuven,Reference Center for Biological Markers of Dementia (BIODEM), Institute Born

[15] KU Leuven,Bunge

[16] Universitat Autonoma de Barcelona,Department of Neurology, UZ Brussel and Center for Neurosciences

[17] Barcelonaβeta Brain Research Center (BBRC),Department of Psychiatry at School of Medical Sciences

[18] Alzheimer’s Disease Unit and Other Cognitive Disorders Unit,Department of Geriatric Psychiatry, Zentralinstitut Für Seelische Gesundheit

[19] Hospital Clinic de Barcelona,Department of Biomedical Sciences

[20] University of Antwerp,Lübeck Interdisciplinary Platform for Genome Analytics, Institutes of Neurogenetics and Cardiogenetics

[21] Vrije Universiteit Brussel,Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience

[22] Örebro University,Neurochemistry Laboratory, Department of Clinical Chemistry

[23] University of Heidelberg,Center for Lifespan Changes in Brain and Cognition, Dept. of Psychology

[24] Complex Genetics Group,Department of Neurodegenerative Disease

[25] VIB Center for Molecular Neurology,undefined

[26] VIB,undefined

[27] University of Antwerp,undefined

[28] University of Lübeck,undefined

[29] Jansen UK,undefined

[30] AC Immune SA,undefined

[31] Vrije Universiteit Amsterdam,undefined

[32] Amsterdam University Medical Centers (AUMC),undefined

[33] Amsterdam Neuroscience,undefined

[34] University of Oslo,undefined

[35] UCL Institute of Neurology,undefined

[36] Dementia Research Institute at UCL,undefined

来源：

Molecular Neurodegeneration | / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Prostaglandin-D-synthase levels in cerebrospinal fluid associated with altered tau proteins in patients with suspected Alzheimer's disease
Morell-Garcia, D.
Ballesteros-Vizoso, M. A.
Bauca, J. M.
Garcia-Martin, A.
Tarongi, S.
Amer, G.
Barcelo, A.
CLINICA CHIMICA ACTA, 2022, 530 : S352 - S352
[22] Homocysteine Metabolism and Cerebrospinal Fluid Markers for Alzheimer's Disease
Popp, Julius
Lewczuk, Piotr
Linnebank, Michael
Cvetanovska, Gabriela
Smulders, Yvo
Koelsch, Heike
Frommann, Ingo
Kornhuber, Johannes
Maier, Wolfgang
Jessen, Frank
JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (04) : 819 - 828
[23] Cerebrospinal fluid oxidative stress markers in Alzheimer's disease
Sakakibara, Ryuji
Kawai, Takayuki
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 232 - 240
[24] Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
Ravaglia, Sabrina
Bini, Paola
Sinforiani, Elena
Franciotta, Diego
Zardini, Elisabetta
Tosca, Pietro
Moglia, Arrigo
Costa, Alfredo
NEUROLOGICAL SCIENCES, 2008, 29 (06) : 417 - 423
[25] Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer’s disease and vascular dementia
Sabrina Ravaglia
Paola Bini
Elena Sinforiani
Diego Franciotta
Elisabetta Zardini
Pietro Tosca
Arrigo Moglia
Alfredo Costa
Neurological Sciences, 2008, 29
[26] Elevated cerebrospinal fluid total Tau levels reflects predominant cortical involvement in Alzheimer's disease
Pillai, Jagan
Khrestian, Maria
Bekris, Lynn
Safar, Jiri
Leverenz, James
NEUROLOGY, 2017, 88
[27] Tau and β-amyloid levels in cerebrospinal fluid of patients with dementia with lewy bodies in comparison with Alzheimer's disease
Gómez-Tortosa, E
Yébenes, JG
Jiménez-Díaz, FJ
Gonzalo, I
Fanjul, S
Cemillán, F
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S382 - S382
[28] Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions
Teitsdottir, Unnur D.
Jonsdottir, Maria K.
Lund, Sigrun H.
Darreh-Shori, Taher
Snaedal, Jon
Petersen, Petur H.
ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
[29] Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
Unnur D. Teitsdottir
Maria K. Jonsdottir
Sigrun H. Lund
Taher Darreh-Shori
Jon Snaedal
Petur H. Petersen
Alzheimer's Research & Therapy, 12
[30] Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease
Umesh Gangishetti
J. Christina Howell
Richard J. Perrin
Natalia Louneva
Kelly D. Watts
Alexander Kollhoff
Murray Grossman
David A. Wolk
Leslie M. Shaw
John C. Morris
John Q. Trojanowski
Anne M. Fagan
Steven E. Arnold
William T. Hu
Alzheimer's Research & Therapy, 10

← 1 2 3 4 5 →